Freynhofer Matthias K - 3rd Medical Department with Cardiology and Intensive Care Medicine, Wilhelminen Hospital

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 79 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of an Ultra-Endurance Marathon on Cardiac Function in Association with Cardiovascular Biomarkers

Achim Leo Burger,Claudia Wegberger,Maximilian Tscharre,Christoph C. Kaufmann,Marie Muthspiel,Edita Pogran,Matthias K. Freynhofer, Alexander Szalay,Kurt Huber,Bernhard Jäger

Sports Medicine - Openno. 1 (2024): 1-8

Cited0Views0WOSBibtex

Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary intervention

Maximilian Tscharre,Serdar Farhan,Matthias K Freynhofer,Birgit Vogel,Florian Tinhofer,Miklos Rohla,Thomas W Weiss, Johan Wojta,Kurt Huber,Ioannis Tentzeris,Cihan Ay

Thrombosis research (2023): 127-130

Cited0Views0WOSBibtex

Useful Aid or Futile Hassle - Continuous Rhythm Monitoring Following Acute Myocardial Infarction

L. T. Hamacher, N. El Kilany, J. Jost,M. Rohla, B. Panzer, L. Pilz,C. Kaufmann,E. Pogran, A. Burger, A. Ahmed,M. Freynhofer,F. Tinhofer, K. Huber,D. Zweiker

WIENER KLINISCHE WOCHENSCHRIFT (2023): S391-S392

Cited0Views0Bibtex

Multisystem Inflammatory Syndrome in Adults in a Young Male Following Severe Acute Respiratory Syndrome Coronavirus-2 Infection: a Case Report

Christoph C. Kaufmann,Alexander Simon,David Reinhart-Mikocki,Sabine Publig,Kurt Huber,Matthias K. Freynhofer

EUROPEAN HEART JOURNAL-CASE REPORTS（2022）

Cited2Views0WOSBibtex

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Maximilian Tscharre,Serdar Farhan,Matthias K. Freynhofer,Michael Leutner,Sabina Baumgartner-Parzer,Ioannis Tentzeris,Birgit Vogel,Florian Tinhofer,Miklos Rohla,Thomas W. Weiss,Kurt Huber,Alexandra Kautzky-Willer

Frontiers in Cardiovascular Medicine（2022）

Cited6Views0WOSBibtex

Improvement of Outcome Prediction of Hospitalized Patients with COVID-19 by a Dual Marker Strategy Using High-Sensitive Cardiac Troponin I and Copeptin

Kaufmann Christoph C.,Ahmed Amro,Kassem Mona,Freynhofer Matthias K.,Jäger Bernhard,Aicher Gabriele,Equiluz-Bruck Susanne,Spiel Alexander O.,Vafai-Tabrizi Florian,Sigmund Freud University,Fasching Peter, Ludwig Boltzmann Institute for Cardiovascular Research,Giannitsis Evangelos

European Heart Journal（2021）

Cited3Views0WOSBibtex

Copeptin Refines the Prognostic Value of High-Sensitive Cardiac Troponin I in Hospitalized Patients with COVID-19: a Prospective Single-Center Study

C. C. Kaufmann, A. Ahmed,M. Kassem,M. Freynhofer,B. Jager, G. Aicher,S. Equiluz-Bruck,A. Spiel,G. Funk,M. Gschwantler,P. Fasching,J. Wojta,K. Huber

WIENER KLINISCHE WOCHENSCHRIFT（2021）

Cited0Views0Bibtex

Von Willebrand Factor and ADAMTS13 and Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Maximilian Tscharre,Ioannis Tentzeris,Birgit Vogel,Matthias K. Freynhofer,Florian Egger,Miklos Rohla,Thomas W. Weiss, Johan Wojta,Kurt Huber,Serdar Farhan,Cihan Ay

Thrombosis research（2020）

Cited9Views0WOSBibtex

Corrigendum to “uric Acid is Associated with Long-Term Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention” [atherosclerosis 270 (2018) 173–179]

Maximilian Tscharre,Robert Herman,Miklos Rohla, Christina Hauser,Serdar Farhan,Matthias K. Freynhofer,Kurt Huber,Thomas W. Weiss

Atherosclerosis (2020): 96-96

Cited0Views0WOSBibtex

Immature Cell Fractions after Cessation of Chronic P2Y12-inhibition in Patients with Coronary Artery Diseases

Bernhard Jaeger,Kris G. Vargas,Paul M. Haller,Stefan Stojkovic,Christoph C. Kaufmann,Matthias Freynhofer,Peter Quehenberger,Oswald Wagner,Johann Wojta,Kurt Huber

Platelets（2020）

Cited2Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn